These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 35696319)
41. Biophysical, Biochemical, and Behavioral Implications of ApoE3 Conjugated Donepezil Nanomedicine in a Aβ Krishna KV; Saha RN; Dubey SK ACS Chem Neurosci; 2020 Dec; 11(24):4139-4151. PubMed ID: 33251785 [TBL] [Abstract][Full Text] [Related]
42. Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer's Diseases. Wang X; Ho SL; Poon CY; Yan T; Li HW; Wong MS Curr Alzheimer Res; 2019; 16(9):836-842. PubMed ID: 31453789 [TBL] [Abstract][Full Text] [Related]
43. Nanotechnology in the diagnostic and therapy for Alzheimer's disease. Panghal A; Flora SJS Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130559. PubMed ID: 38191034 [TBL] [Abstract][Full Text] [Related]
44. Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates. Barbara R; Belletti D; Pederzoli F; Masoni M; Keller J; Ballestrazzi A; Vandelli MA; Tosi G; Grabrucker AM Int J Pharm; 2017 Jun; 526(1-2):413-424. PubMed ID: 28495580 [TBL] [Abstract][Full Text] [Related]
45. Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease. Resende R; Marques SC; Ferreiro E; Simões I; Oliveira CR; Pereira CM Neurochem Res; 2013 Apr; 38(4):797-806. PubMed ID: 23389658 [TBL] [Abstract][Full Text] [Related]
46. Modeling Amyloid-β42 Toxicity and Neurodegeneration in Adult Zebrafish Brain. Bhattarai P; Thomas AK; Cosacak MI; Papadimitriou C; Mashkaryan V; Zhang Y; Kizil C J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155703 [TBL] [Abstract][Full Text] [Related]
47. Deciphering the Potential Neuroprotective Effects of Luteolin against Aβ Ahmad S; Jo MH; Ikram M; Khan A; Kim MO Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502488 [TBL] [Abstract][Full Text] [Related]
48. Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Yang J; Wadghiri YZ; Hoang DM; Tsui W; Sun Y; Chung E; Li Y; Wang A; de Leon M; Wisniewski T Neuroimage; 2011 Apr; 55(4):1600-9. PubMed ID: 21255656 [TBL] [Abstract][Full Text] [Related]
49. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model. Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821 [TBL] [Abstract][Full Text] [Related]
50. Chitosan-coated Selenium nanoparticles enhance the efficiency of stem cells in the neuroprotection of streptozotocin-induced neurotoxicity in male rats. Soleimani Asl S; Amiri I; Samzadeh-Kermani A; Abbasalipourkabir R; Gholamigeravand B; Shahidi S Int J Biochem Cell Biol; 2021 Dec; 141():106089. PubMed ID: 34601090 [TBL] [Abstract][Full Text] [Related]
51. MicroRNA-23b attenuates tau pathology and inhibits oxidative stress by targeting GnT-III in Alzheimer's disease. Pan K; Chen S; Wang Y; Yao W; Gao X Neuropharmacology; 2021 Sep; 196():108671. PubMed ID: 34153312 [TBL] [Abstract][Full Text] [Related]
52. Reversing pathology in a preclinical model of Alzheimer's disease by hacking cerebrovascular neoangiogenesis with advanced cancer therapeutics. Singh CSB; Choi KB; Munro L; Wang HY; Pfeifer CG; Jefferies WA EBioMedicine; 2021 Sep; 71():103503. PubMed ID: 34534764 [TBL] [Abstract][Full Text] [Related]
53. Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients. Bhattacharya S Curr Pharm Biotechnol; 2023; 24(9):1108-1121. PubMed ID: 36305141 [TBL] [Abstract][Full Text] [Related]
54. Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Ali T; Kim MO J Pineal Res; 2015 Aug; 59(1):47-59. PubMed ID: 25858697 [TBL] [Abstract][Full Text] [Related]
55. A novel antibody targeting sequence 31-35 in amyloid β protein attenuates Alzheimer's disease-related neuronal damage. Cheng L; Zhang J; Li XY; Yuan L; Pan YF; Chen XR; Gao TM; Qiao JT; Qi JS Hippocampus; 2017 Feb; 27(2):122-133. PubMed ID: 27784133 [TBL] [Abstract][Full Text] [Related]
56. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ Amin FU; Shah SA; Badshah H; Khan M; Kim MO J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812 [TBL] [Abstract][Full Text] [Related]
57. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease. Wu X; Kosaraju J; Zhou W; Tam KY ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988 [TBL] [Abstract][Full Text] [Related]
58. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior. Sharma S; Verma S; Kapoor M; Saini A; Nehru B Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920 [TBL] [Abstract][Full Text] [Related]
59. Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice. Ahmad A; Ali T; Park HY; Badshah H; Rehman SU; Kim MO Mol Neurobiol; 2017 Apr; 54(3):2269-2285. PubMed ID: 26944285 [TBL] [Abstract][Full Text] [Related]